Superworth

Pfizer PE ratio PFE

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Oct 23, 2026
39.5×
10-year median
15.8×
Against its 10-year history
98th
percentile: 0 is its lowest day, 100 its highest
10-year range
6.9× to 77.6×
Peer median
42.7×

Pfizer's PE ratio is 39.5× as of Oct 23, 2026: a share price of $30.03 against $0.76 of earnings per share over the last twelve months.

That is above its ten-year median of 15.8×, higher than on 98% of days in the last ten years.

Over that time it ranged from 6.9× in Aug 2023 to 77.6× in Mar 2024.

The median for 8 large drugmakers of a similar size is 42.7×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far39.5×14.6×39.5×
202514.6×12.6×36.1×
202436.0×14.7×77.6×
202315.7×6.9×16.7×
20229.9×8.3×16.6×
202117.6×14.8×24.0×
202023.7×9.6×26.5×
201913.0×9.8×22.1×
201810.3×9.3×22.8×
201721.2×20.6×31.9×
201630.8×20.7×31.1×
201523.0×18.3×24.2×
201418.5×7.9×18.7×
20138.1×7.3×20.3×
201218.3×13.8×18.8×
201114.1×12.1×23.8×
201021.6×12.0×21.7×

Against its peers

Companies in Drug Manufacturers - General nearest Pfizer's size, closest first, today.

CompanyPE ratio
PFEPfizer39.5×
GILDGilead Sciencesn/m
BMYBristol-Myers Squibb13.5×
AMGNAmgen27.3×
MRKMerck116×
ABBVAbbVie80.7×
JNJJohnson & Johnson40.0×
BIIBBiogen44.4×
LLYEli Lilly and42.7×
Peer median42.7×

Where Pfizer ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Pfizer

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.